Cancer drugs funding

Proposals for revamped cancer drugs fund offer faster access to most promising drugs

New proposals have been drawn up for a revamped cancer drugs fund after the present model was branded unsustainable.…

Everolimus is available to patients in Wales after deal agreed with Novartis

Everolimus has been made available to treat patients in Wales with certain types of renal, pancreatic or breast cancers, or non-cancerous brain or kidney tumours associated with tuberous sclerosis complex.…

Who decides the true value of a medicine?

Determining the real worth of a treatment means more than just measuring the effect on clinical symptoms.…

The sustainability of the Cancer Drugs Fund

Elizabeth Sukkar, the journal’s deputy news editor, asks key opinion leaders from NICE, the ABPI, the NHS and Myeloma UK on the sustainability of the Cancer Drugs Fund considering it is massively over budget.…

NICE sees role for Cancer Drugs Fund but on a different basis, RPS conference hears

The National Institute for Health and Care Excellence (NICE) sees a role for the Cancer Drugs Fund, but it needs to be on a different footing, according to NICE’s programme director of technology appraisals.…

Cancer Drugs Fund needs overhaul, NAO investigation finds

The Cancer Drugs Fund is unsustainable in its current form because of overspending and a lack of evidence on the results it yields, according to a report from the National Audit Office.…

Encouraging pharmaceutical innovation must come first

The ‘de-listing’ of certain treatments from the NHS Cancer Drugs Fund was inevitable with budgets becoming tighter but innovation in drug development must not suffer.…

NHS England cuts treatments from Cancer Drugs Fund

After a second assessment of the Cancer Drugs Fund, NHS England has further reduced the list by 17 drugs for 23 different indications.…

Clinical Pharmacist’s monthly news round-up: the top 10 in the past month

What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…

Proposal to involve NICE in approval process for Cancer Drugs Fund

The evaluation of drugs currently funded under the Cancer Drugs Fund (CDF) could be passed over to National Institute for Health and Care Excellence (NICE) under proposals drawn up by NHS England.…